Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Withdrawn NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been withdrawn from the NGC Web site. Select "All" to see a complete list of withdrawn NGC Guideline Summaries (organized alphabetically by guideline developer). For a list of guidelines that have been updated, go to Updated NGC Summaries.

Guideline summaries are removed from the NGC Web site because they no longer meet the NGC Inclusion Criteria with respect to date, or because the guideline developer has indicated that the clinical practice guideline upon which the summary is based is obsolete, should no longer be used, or has not yet been replaced with a new/revised guideline. Please refer to the guideline developer's Web site, where available, for more information.

Note to PC users: If you are not sure which developer you need, consider using the "Find" option under the Edit menu or select Control-F to search the complete list by keyword.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1140 guidelines in the withdrawn archive.

California Department of Developmental Services

  1. Autistic spectrum disorders. Best practice guidelines for screening, diagnosis and assessment. (NGC-4601)
    • California Department of Developmental Services. Autistic spectrum disorders. Best practice guidelines for screening, diagnosis and treatment. Sacramento (CA): California Department of Developmental Services; 2002. 183 p. [220 references]

Canadian Task Force on Preventive Health Care

  1. Acetylsalicylic acid and the primary prevention of cardiovascular disease. (NGC-1288)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Acetylsalicylic acid and the primary prevention of cardiovascular disease. p. 680-90. [13 references]

  2. Administration of pneumococcal vaccine. (NGC-1266)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Administration of pneumococcal vaccine. p. 386-95. [25 references]

  3. Asymptomatic carotid disease. (NGC-1289)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Asymptomatic carotid disease. p. 692-704. [34 references]

  4. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. (NGC-2083)
    • Levine M, Moutquin JM, Walton R, Feightner J. Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ 2001 Jun 12;164(12):1681-90. [21 references]

  5. Childhood immunizations. (NGC-1265)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Childhood immunizations. p. 372-84. [29 references]

  6. Children of alcoholics. (NGC-1273)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Children of alcoholics. p. 470-85. [57 references]

  7. Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease. (NGC-1270)
    • Canadian Task Force on Preventive Health Care. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Dipstick proteinuria screening of asymptomatic adults to prevent progressive renal disease. p. 436-45. [41 references]

  8. Disadvantaged children. (NGC-1264)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Disadvantaged children. p. 356-68. [28 references]

  9. Early detection and counselling of problem drinking. (NGC-1274)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care . Ottawa (Canada): Health Canada; 1994 . Early detection and couselling of problem drinking. p. 488-98. [20 references]

  10. Early detection of depression. (NGC-1271)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Early detection of depression. p. 450-4. [8 references]

  11. Hepatitis B immunization in childhood. (NGC-1267)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Hepatitis B immunization in childhood. p. 398-404. [13 references]

  12. Hypertension in the elderly: case-finding and treatment to prevent vascular disease. (NGC-1311)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Hypertension in the elderly: case-finding and treatment to prevent vascular disease. p. 944-51. [15 references]

  13. Interventions other than smoking cessation to prevent lung cancer. (NGC-1296)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Interventions other than smoking cessation to prevent lung cancer. p. 780-6. [36 references]

  14. Intrapartum electronic fetal monitoring. (NGC-1247)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Intrapartum electronic fetal monitoring. p. 158-65. [15 references]

  15. Lowering the blood total cholesterol level to prevent coronary heart disease. (NGC-1286)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Lowering the blood total cholesterol level to prevent coronary heart disease. p. 650-9. [43 references]

  16. Nutritional counselling for undesirable dietary patterns and screening for protein/calorie malnutrition disorders in adults. (NGC-1281)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Nutritional counselling for undesirable dietary patterns and screening for protein/calorie malnutrition disorders in adults. p. 586-99. [41 references]

  17. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. (NGC-1280)
    • Douketis JD, Canadian Task Force on Preventive Health Care, Feightner JW, Attia J, Feldman WF. Periodic health examination, 1999 update: 1. Detection, prevention and treatment of obesity. CMAJ 1999 Feb 23;160(4):513-25. [128 references] PubMed

  18. Physical activity counselling. (NGC-1279)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Physical activity counselling. p. 560-9. [24 references]

  19. Prenatal screening and diagnosis for Down syndrome prevention. (NGC-1240)
    • Canadian Task Force on Preventive Health Care, Dick PT. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. CMAJ 1996 Feb 15;154(4):465-79. [158 references] PubMed

  20. Preschool screening for developmental problems. (NGC-1258)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Preschool screening for developmental problems. p. 290-6. [20 references]

  21. Prevention of dental caries. (NGC-1268)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 2. Prevention of dental caries. CMAJ 1995 Mar 15;152(6):836-46. [70 references] PubMed

  22. Prevention of gonorrhea. (NGC-1291)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of gonorrhea. p. 720-9. [23 references]

  23. Prevention of group B streptococcal infection in newborns. (NGC-2433)
    • Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2002 Apr 2;166(7):928-30. [25 references] PubMed

  24. Prevention of hearing impairment and disability in the elderly. (NGC-1312)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of hearing impairment and disability in the elderly. p. 954-63. [29 references]

  25. Prevention of household and recreational injuries in adults. (NGC-1277)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in adults. p. 526-37. [23 references]

  26. Prevention of household and recreational injuries in children (<15 years of age). (NGC-1260)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in children (<15 years of age). p. 306-17. [29 references]

  27. Prevention of household and recreational injuries in the elderly. (NGC-1308)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of household and recreational injuries in the elderly. p. 912-20. [22 references]

  28. Prevention of influenza. (NGC-1293)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of influenza. p. 744-51. [19 references]

  29. Prevention of iron deficiency enemia in infants. (NGC-1255)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinica Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Prevention of iron deficiency enemia in infants. p. 244-55. [21 references]

  30. Prevention of low birth weight/preterm birth. (NGC-1236)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of low birth weight/preterm birth. p. 38-50. [28 references]

  31. Prevention of motor vehicle accident injuries. (NGC-1276)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of motor vehicle accident injuries. p. 514-24. [18 references]

  32. Prevention of neonatal herpes simplex. (NGC-1242)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of neonatal herpes simplex. p. 108-14. [8 references]

  33. Prevention of osteoporotic fractures in women by estrogen replacement therapy. (NGC-1284)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of osteoporotic fractures in women by estrogen replacement therapy. p. 620-31. [46 references]

  34. Prevention of pancreatic cancer. (NGC-1303)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of pancreatic cancer. p. 850-9. [20 references]

  35. Prevention of periodontal disease. (NGC-1269)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of periodontal disease. p. 420-31. [36 references]

  36. Prevention of preeclampsia. (NGC-1245)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of preeclampsia. p. 136-43. [24 references]

  37. Prevention of skin cancer. (NGC-1302)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of skin cancer. p. 850-9. [43 references]

  38. Prevention of suicide. (NGC-1272)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of suicide. p. 456-67. [42 references]

  39. Prevention of tobacco-caused disease. (NGC-1275)
    • Taylor MC, Dingle JL. Prevention of tobacco-caused disease. In: Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. p. 500-11. [45 references]

  40. Prevention of unintended pregnancy and sexually transmitted diseases in adolescents. (NGC-1278)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prevention of unintended pregnancy and sexually transmitted diseases in adolescents. p. 540-57. [31 references]

  41. Preventive health care, 1999 update. Follow-up after breast cancer. (NGC-1930)
    • Temple LK, Wang EE, McLeod RS. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care. CMAJ 1999 Oct 19;161(8):1001-8. [50 references]

  42. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. (NGC-1931)
    • Kapral MK, Silver FL. Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care. CMAJ 1999 Oct 19;161(8):989-96. [96 references]

  43. Preventive health care, 1999 update: prevention of oral cancer mortality. (NGC-1932)
    • Hawkins RJ, Wang EE, Leake JL. Preventive health care, 1999 update: prevention of oral cancer mortality. Canadian Task Force on Preventive Health Care. J Can Dent Assoc 1999 Dec;65(11):617. [119 references]

  44. Preventive health care, 2000 update. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. (NGC-1929)
    • Bell C, Kapral M. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. Canadian Task Force on Preventive Health Care. Can J Neurol Sci 2000 Feb;27(1):25-31. [78 references]

  45. Preventive health care, 2000 update: prevention of child maltreatment. (NGC-1927)
    • MacMillan HL. Preventive health care, 2000 update: prevention of child maltreatment. CMAJ 2000 Nov 28;163(11):1451-8. [44 references] PubMed

  46. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. (NGC-1928)
    • Booth GL, Wang EE. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. Canadian Task Force on Preventive Health Care. CMAJ 2000 Jul 11;163(1):21-9. [107 references]

  47. Preventive health care, 2001 update: colorectal cancer screening. (NGC-2120)
    • Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001 Jul 24;165(2):206-8. [20 references] PubMed

  48. Preventive health care, 2001 update: Screening and management of developmental dysplasia of the hip in newborns. (NGC-2082)
    • Patel H. Preventive health care, 2001 update: screening and management of developmental dysplasia of the hip in newborns. CMAJ 2001 Jun 12;164(12):1669-77. [69 references]

  49. Preventive health care, 2001 update: Screening mammography among women aged 40-49 years at average risk of breast cancer. (NGC-1938)
    • Ringash J. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ 2001 Feb 20;164(4):469-76. [76 references]

  50. Preventive health care, 2001 update: Should women be routinely taught breast self-examination to screen for breast cancer? (NGC-2084)
    • Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?. CMAJ 2001 Jun 26;164(13):1837-46. [78 references]

  51. Primary and secondary prevention of neural tube defects. (NGC-1239)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary and secondary prevention of neural tube defects. p. 74-81. [16 references]

  52. Primary prevention of fetal alcohol syndrome. (NGC-1237)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Primary prevention of fetal alcohol syndrome. p. 52-61. [28 references]

  53. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. (NGC-1248)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Prophylaxis for gonococcal and chlamydial ophthalmia neonatorum. p. 168-75. [9 references]

  54. Routine iron supplementation during pregnancy. (NGC-1238)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine iron supplementation during pregnancy. p. 64-72. [11 references]

  55. Routine prenatal ultrasound screening. (NGC-1233)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine prenatal ultrasound screening. p. 4-14. [18 references]

  56. Routine preschool screening for visual and hearing problems. (NGC-1259)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Routine preschool screening for visual and hearing problems. p. 298-304. [11 references]

  57. Screening and isoniazid prophylactic therapy for tuberculosis. (NGC-1294)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening and isoniazid prophylactic therapy for tuberculosis. p. 754-65. [19 references]

  58. Screening and vaccinating adolescents and adults to prevent congenital rubella syndrome. (NGC-1244)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening and vaccinating adolescents and adults to prevent congenital rubella syndrome. p. 126-33. [19 references]

  59. Screening children for lead exposure in Canada. (NGC-1257)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening children for lead exposure in Canada. p. 268-88. [80 references]

  60. Screening for abdominal aortic aneurysm. (NGC-1287)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for abdominal aortic aneurysm. p. 672-8. [19 references]

  61. Screening for asymptomatic bacteriuria in pregnancy. (NGC-1241)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for asymptomatic bacteriuria in pregnancy. p. 100-6. [15 references]

  62. Screening for asymptomatic bacteriuria in the elderly. (NGC-1313)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for asymptomatic bacteriuria in the elderly. p. 966-73. [19 references]

  63. Screening for bladder cancer. (NGC-1300)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for bladder cancer. p. 826-36. [20 references]

  64. Screening for breast cancer. (NGC-1297)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994 . Screening for breast cancer. p. 788-95. [31 references]

  65. Screening for cervical cancer. (NGC-1305)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for cervical cancer. p. 870-81. [41 references]

  66. Screening for childhood obesity. (NGC-1262)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for childhood obesity. p. 334-44. [33 references]

  67. Screening for chlamydial infection. (NGC-1292)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. CMAJ 1996 Jun 1;154(11):1631-44. [201 references] PubMed

  68. Screening for cognitive impairment and dementia in the elderly. (NGC-2035)
    • Patterson CJ, Gass DA. Screening for cognitive impairment and dementia in the elderly. Can J Neurol Sci 2001 Feb;28(Suppl 1):S42-51. [94 references]

  69. Screening for congenital hypothyroidism. (NGC-1250)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for congenital hypothyroidism. p. 190-4. [10 references]

  70. Screening for cystic fibrosis. (NGC-1251)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for cystic fibrosis. p. 196-204. [25 references]

  71. Screening for D (Rh) sensitization in pregnancy. (NGC-1243)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for D (Rh) sensitization in pregnancy. p. 116-24. [12 references]

  72. Screening for gestational diabetes mellitus. (NGC-1234)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for gestational diabetes mellitus. p. 16-23. [19 references]

  73. Screening for hemoglobinopathies in Canada. (NGC-1252)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for hemoglobinopathies in Canada. p. 206-18. [25 references]

  74. Screening for HIV antibody. (NGC-1290)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for HIV antibody. p. 708-18. [37 references]

  75. Screening for human papillomavirus infection. (NGC-1295)
    • Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for human papillomavirus infection. p. 768-76. [33 references]

  76. Screening for hypertension in young and middle-aged adults. (NGC-1285)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for hypertension in young and middle-aged adults. p. 636-48. [43 references]

  77. Screening for idiopathic adolescent scoliosis. (NGC-1263)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for idiopathic adolescent scoliosis. p. 346-54. [37 references]

  78. Screening for otitis media with effusion. Recommendation statement from the Canadian Task Force on Preventive Health Care. (NGC-2297)
    • Screening for otitis media with effusion. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001 Oct 16;165(8):1092-3. [11 references]

  79. Screening for ovarian cancer. (NGC-1304)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for ovarian cancer. p. 870-81. [41 references]

  80. Screening for phenylketonuria. (NGC-1249)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for phenylketonuria. p. 180-8. [29 references]

  81. Screening for prostate cancer. (NGC-1299)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for prostate cancer. p. 812-23. [29 references]

  82. Screening for testicular cancer. (NGC-1306)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for testicular cancer. p. 892-8. [22 references]

  83. Screening for thyroid disorders and thyroid cancer in asymptomatic adults. (NGC-1283)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Screening for thyroid disorders and thyroid cancer in asymptomatic adults. p. 612-8. [14 references]

  84. Screening for urinary infection in asymptomatic infants and children. (NGC-1253)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care . Ottawa (Canada): Health Canada; 1994. Screening for urinary infection in asymptomatic infants and children. p. 220-30. [36 references]

  85. Screening for visual impairment in the elderly. (NGC-1310)
    • The Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1995 update: 3. Screening for visual problems among elderly patients. CMAJ 1995 Apr 15;152(8):1211-22. [102 references] PubMed

  86. Secondary prevention of elder abuse. (NGC-1309)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Secondary prevention of elder abuse. p. 922-9. [20 references]

  87. Smoking and pregnancy. (NGC-1235)
    • Canadian Task Forceon Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Smoking and pregnancy. p. 26-36. [35 references]

  88. The use of home uterine activity monitoring to prevent preterm birth. (NGC-1246)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Use of home uterine activity monitoring to prevent preterm birth. p. 146-55. [15 references]

  89. Varicella vaccination. Recommendation statement from the Canadian Task Force on Preventive Health Care. (NGC-2085)
    • Varicella vaccination. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 2001 Jun 26;164(13):1888-9. [97 references]

  90. Well-baby care in the first 2 years of life. (NGC-1256)
    • Canadian Task Force on Preventive Health Care. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa (Canada): Health Canada; 1994. Well-baby care in the first 2 years of life. p. 258-66. [12 references]

For more information, please refer to the Canadian Task Force on Preventive Health Care Web site.

Center for Biosecurity

  1. (1) Botulinum toxin as a biological weapon: medical and public health management. (2) Botulinum toxin as a biological weapon. (Addendum) (NGC-2845)
    • Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K. Botulinum toxin as a biological weapon. In: Henderson DA, Inglesby TV, O'Toole T, editor(s). Bioterrorism : guidelines for medical and public health management. Chicago (IL): American Medical Association; 2002. p. 141-65. [109 references]


    • Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001 Feb 28;285(8):1059-70. [106 references]

  2. (1) Smallpox as a biological weapon: medical and public health management. (2) Smallpox as a biological weapon. (Addendum) (NGC-2838)
    • Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl T, Russell PK, Tonat K. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999 Jun 9;281(22):2127-37. [51 references] PubMed


    • Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, Hauer J, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. Smallpox as a biological weapon. In: Henderson DA, Inglesby TV, O'Toole T, editor(s). Bioterrorism : guidelines for medical and public health management. Chicago (IL): American Medical Association; 2002. p. 99-120. [53 references]

  3. Anthrax as a biological weapon, 2002: updated recommendations for management. (NGC-2446)
    • Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 2002 May 1;287(17):2236-52. [114 references] PubMed

  4. Hemorrhagic fever viruses as biological weapons: medical and public health management. (NGC-2450)
    • Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O'Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002 May 8;287(18):2391-405. [140 references] PubMed

  5. Plague as a biological weapon. Medical and public health management. (NGC-2209)
    • Inglesby TV, Dennis DT, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Koerner JF, Layton M, McDade J, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Schoch-Spana M, Tonat K. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000 May 3;283(17):2281-90. [72 references]

  6. Tularemia as a biological weapon. Medical and public health management. (NGC-2207)
    • Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K. Tularemia as a biological weapon: medical and public health management. JAMA 2001 Jun 6;285(21):2763-73. [102 references]

For more information, please refer to the Center for Biosecurity Web site.

Centers for Disease Control and Prevention

  1. (1) Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    (2) Notice to readers: Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. (NGC-1604)
    • Centers for Disease Control and Prevention. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998 May 22;47(RR-8):1-57. [229 references] PubMed


    • Notice to readers: Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Recomm Rep 2001 Dec 14;50(49):1117. [2 references]

  2. (1) Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices. (2) Notice to readers: use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. (NGC-5209)
    • Centers for Disease Control and Prevention (CDC). Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2002 Nov 15;51(45):1024-6. PubMed


    • Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2000 Dec 15;49(RR-15):1-21. [87 references]

  3. 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. (NGC-2306)
    • 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Rockville (MD): U.S. Department of Health and Human Services, Public Health Service; 2001 Nov 28. 64 p. [145 references]


    • Centers for Disease Control and Prevention. Guidelines for preventing opportunistic infections among HIV-infected persons -- 2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002 Jun 14;51(RR-8):1-52. [145 references]

  4. Acute otitis media: management and surveillance in an era of pneumococcal resistance. (NGC-0931)
    • Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, Rakowsky A, Schwartz B. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999 Jan;18(1):1-9. [33 references] PubMed

  5. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. (NGC-1378)
    • Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: Revised recommendations. MMWR Recomm Rep 1997 Sep 5;46(RR-15):1-10. [49 references] PubMed

  6. Combination vaccines for childhood immunization. (NGC-1205)
    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. Am Fam Physician 1999 May 1;59(9):2565-74. PubMed


    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. MMWR Recomm Rep 1999 May 14;48(RR-5):1-14. PubMed


    • Advisory Committee on Immunization Practices (ACIP), American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP). Combination vaccines for childhood immunization. Pediatrics 1999 May;103(5 Pt 1):1064-77. [80 references] PubMed

  7. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. (NGC-2100)
    • Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR Recomm Rep 2001 Jul 13;50(RR-12):1-23. [22 references]

  8. Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. (NGC-2710)
    • Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for hand hygiene in health-care settings. MMWR Recomm Rep 2002 Oct 25;51(RR-16):1-48. [423 references]

  9. Guideline for infection control in hospital personnel. (NGC-0844)
    • Center for Disease Control and Prevention (CDC). Guideline for infection control in health care personnel, 1998. Springfield (VA): Hospital Infections Program, NTIS U.S. Dept of Commerce, Center for Disease Control and Prevention (CDC); 1998. 42 p. [81 references]

  10. Guideline for prevention of surgical site infection, 1999. (NGC-1071)
    • Centers for Disease Control and Prevention. Guideline for prevention of surgical site infection, 1999 . Am J Infect Control 1999 Apr;27(2):97-132. [497 references] PubMed


    • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999 Apr;20(4):250-78; quiz 279-80. [497 references] PubMed

  11. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. (NGC-1799)
    • Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6(6a):659-713; 715; 717-27; quiz 729-33. [410 references]


    • Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm Rep 2000 Oct 20;49(RR-10):1-125. [410 references] PubMed

  12. Guidelines for school programs to prevent skin cancer. (NGC-2445)
    • Centers for Disease Control and Prevention. Guidelines for school programs to prevent skin cancer. MMWR Recomm Rep 2002 Apr 26;51(RR-4):1-18. [145 references]

  13. Guidelines for the prevention of intravascular catheter-related infections. (NGC-2613)
    • O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA. Guidelines for the prevention of intravascular catheter-related infections [published erratum appears in MMWR Weekly 2002 Aug 16;51(32):71]. MMWR Recomm Rep 2002 Aug 9;51(RR-10):1-29. [293 references] PubMed

  14. Guidelines for the use of antiretroviral agents in pediatric HIV infection. (NGC-3969)
    • Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Bethesda (MD): U.S. Department of Health and Human Services; 2004 Nov 30. 79 p. [204 references]

  15. Hantavirus pulmonary syndrome - United States: updated recommendations for risk reduction. (NGC-2596)
    • Centers for Disease Control and Prevention. Hantavirus pulmonary syndrome--United States: updated recommendations for risk reduction. MMWR Recomm Rep 2002 Jul 26;51(RR-9):1-12. [46 references]

  16. Managing elevated blood lead levels among young children: recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention. (NGC-4568)
    • Centers for Disease Control and Prevention (CDC). Managing elevated blood lead levels among young children: recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 2002 Mar. 128 p. [53 references]

  17. Meningococcal disease and college students: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-1591)

    • Poliomyelitis prevention in the United States. (NGC-1525)
      • Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States. MMWR Recomm Rep 2000 May;49(RR-5):1-22. [81 references]

    • Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices. (NGC-0042)
      • Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997 Jan 24;46(RR-3):1-25. [64 references]

    • Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. (NGC-2629)
      • Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002 Aug 16;51(RR-11):1-22. [142 references]

    • Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0062)
      • Prevention of plague: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1996 Dec 13;45(RR-14):1-15. [37 references]

    • Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0057)
      • Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997 Apr 4;46(RR-8):1-24. [123 references] PubMed

    • Progressing toward tuberculosis elimination in low-incidence areas of the United States. (NGC-2447)
      • Centers for Disease Control and Prevention (CDC). Progressing toward tuberculosis elimination in low-incidence areas of the United States: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 2002 May 3;51(RR-5):1-16. [24 references]

    • Recommendations for blood lead screening of young children enrolled in Medicaid: targeting a group at high risk. (NGC-1964)
      • Recommendations for blood lead screening of young children enrolled in Medicaid: targeting a group at high risk. MMWR Recomm Rep 2000 Dec 8;49(RR-14):1-13. [25 references]

    • Recommendations for preventing transmission of infections among chronic hemodialysis patients. (NGC-2015)
      • Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 2001 Apr 27;50(RR-5):1-43. [54 references]

    • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. (NGC-0744)
      • Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep 1998 Oct 16;47(RR-19):1-39. [158 references]

    • Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. (NGC-1381)
      • Centers for Disease Control and Prevention. Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis Among Foreign-Born Persons. MMWR Recomm Rep 1998 Sep 18;47(RR-16):1-29. [18 references] PubMed

    • Recommendations for the use of Lyme disease vaccine. (NGC-1204)
      • Recommendations for the use of lyme disease vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999 Jun 4;48(RR07):1-17. [80 references]

    • Recommendations for use of haemophilus B conjugate vaccines and a combined diphtheria, tetanus, pertussis, and haemophilus B vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0063)
      • Recommendations for use of haemophilus B conjugate vaccines and a combined diphtheria, tetanus, pertussis, and haemophilus B vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1993 Sep 17;42(RR-13):1-15.

    • Recommendations for using fluoride to prevent and control dental caries in the United States. (NGC-2145)
      • Recommendations for using fluoride to prevent and control dental caries in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001 Aug 17;50(RR-14):1-42. [270 references]

    • Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. (NGC-0049)
      • Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus [published erratum appears in MMWR Morb Mortal Wkly Rep 1994 Aug 12;43(31):531]. MMWR Morb Mortal Wkly Rep 1994 Aug;43(RR-11):1-20.

    • Recommendations regarding selected conditions affecting women's health. (NGC-1503)
      • Centers for Disease Control and Prevention. CDC recommendations regarding selected conditions affecting women's health. MMWR Recomm Rep 2000 Mar 31;49(RR-2):1-76. [171 references]

    • Recommendations to prevent hepatitis B virus transmission-United States-Update. (NGC-1208)
      • Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission--United States. MMWR Recomm Rep 1999 Jan 22;48(2):33-4. [7 references] PubMed

    • School health guidelines to prevent unintentional injuries and violence. (NGC-2338)
      • School health guidelines to prevent unintentional injuries and violence. MMWR Recomm Rep 2001 Dec 7;50(RR-22):1-46. [380 references]

    • Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. (NGC-0073)
      • Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1995 Sep 8;44(RR-11):19-34. PubMed

    • Screening test to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections -- 2002. (NGC-2709)
      • Johnson RE, Newhall WJ, Papp JR, Knapp JS, Black CM, Gift TL, Steece R, Markowitz LE, Devine OJ, Walsh CM, Wang S, Gunter DC, Irwin KL, DeLisle S, Berman SM. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections--2002. MMWR Recomm Rep 2002 Oct 18;51(RR-15):1-38. [160 references] PubMed

    • Screening young children for lead poisoning: guidance for state and local public health officials. (NGC-1965)
      • Centers for Disease Control and Prevention (CDC). Screening young children for lead poisoning: guidance for state and local public health officials. Atlanta (GA): Centers for Disease Control and Prevention (CDC); 1997 Nov. 205 p. [23 references]

    • The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. (NGC-0074)
      • Centers for Disease Control and Prevention, Advisory Council for the Elimination of Tuberculosis, Advisory Committee on Immunization Practices. Role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR Recomm Rep 1996 Apr 26;45(RR-4):1-18. [87 references] PubMed

    • Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). (NGC-0069)
      • Typhoid immunization recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1994 Dec;43(RR-14):1-7. [37 references]

    • U.S. Centers for Disease Control and Prevention (CDC) report regarding selected public health topics affecting women's health. (NGC-2032)
      • CDC report regarding selected public health topics affecting women's health. MMWR Recomm Rep 2001 May 11;50(RR-6):1-48. [79 references]

    • U.S. Public Health Service guideline on infectious disease issues in xenotransplantation. (NGC-2157)
      • U.S. Public Health Service guideline on infectious disease issues in xenotransplantation. Centers for Disease Control and Prevention. MMWR Recomm Rep 2001 Aug 24;50(RR-15):1-46. [131 references]

    • Updated recommendations for use of pneumococcal conjugate vaccine: reinstatement of the third dose. (NGC-3735)
      • Updated recommendations for use of pneumococcal conjugate vaccine: reinstatement of the third dose [published erratum appears in MMWR 2004, Jul 16;53(27):616]. MMWR Morb Mortal Wkly Rep 2004 Jul 9;53(26):589-90.

    • Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. (NGC-2088)
      • Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep 2001 Jun 29;50(RR-11):1-52. [128 references]

    • Vaccinia (smallpox) vaccine. (NGC-2076)
      • Centers for Disease Control and Prevention. Vaccina (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001 Jun 22;50(RR-10):1-25, CE1-7. [89 references]

    • Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. (NGC-2715)
      • Cetron MS, Marfin AA, Julian KG, Gubler DJ, Sharp DJ, Barwick RS, Weld LH, Chen R, Clover RD, Deseda-Tous J, Marchessault V, Offit PA, Monath TP. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002 Nov 8;51(RR-17):1-11. [57 references] PubMed

    For more information, please refer to the Centers for Disease Control and Prevention Web site.

    Cincinnati Children's Hospital Medical Center

    1. Evidence based clinical practice guideline for emergency appendectomy. (NGC-3168)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for emergency appendectomy. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Oct. 9 p. [81 references]

    2. Evidence based clinical practice guideline for management of children with mild traumatic head injury. (NGC-1388)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for management of children with mild traumatic head injury. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2000. 9 p. [69 references]

    3. Evidence based clinical practice guideline for management of hypertension following surgical repair of coarctation of the aorta in children greater than 6 months of age. (NGC-3175)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for management of hypertension following surgical repair of coarctation of the aorta in children >6 months of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2000 Jul 3. 4 p. [9 references]

    4. Evidence based clinical practice guideline for managing an acute exacerbation of asthma. (NGC-2670)
      • Cincinnati Children's Hospital Medical Center. Managing an acute exacerbation of asthma. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Sep 3. 21 p. [130 references]

    5. Evidence based clinical practice guideline for medical management of first unprovoked seizure in children 2 to 18 years of age. (NGC-2752)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for first unprovoked seizure for children 2 to 18 years of age. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Jul 1. 8 p. [35 references]

    6. Evidence based clinical practice guideline for pneumocystis carinii pneumonia prophylaxis following solid organ or blood and marrow transplants. (NGC-3174)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for pneumocystis carinii pneumonia prophylaxis following solid organ or blood and marrow transplants. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2001 Jan 12. 9 p. [80 references]

    7. Evidence based clinical practice guideline for the management of systemic hypertension following orthotopic cardiac transplantation. (NGC-3169)
      • Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for the management of systemic hypertension following orthotopic cardiac transplantation. Cincinnati (OH): Cincinnati Children's Hospital Medical Center; 2002 Apr 5. 9 p. [28 references]

    College of American Pathologists

    1. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. (NGC-1186)
      • Keren DF, Alexanian R, Goeken JA, Gorevic PD, Kyle RA, Tomar RH. Guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies. Arch Pathol Lab Med 1999 Feb;123(2):106-7. PubMed

    2. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. (NGC-1405)
      • College of American Pathologists, American College of Rheumatology, Clinical Immunology Society and Clinical Center. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens . Arch Pathol Lab Med 2000 Jan;124(1):71-81. [53 references]

    3. Practice guidelines for examination of the placenta. (NGC-0218)
      • Langston C, Kaplan C, Macpherson T, Manci E, Peevy K, Clark B, Murtagh C, Cox S, Glenn G. Practice guideline for examination of the placenta: developed by the Placental Pathology Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1997 May;121(5):449-76. [66 references] PubMed

    4. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. (NGC-1409)
      • College of American Pathologists. Practice parameter for the recognition, management, and prevention of adverse consequences of blood transfusion. Arch Pathol Lab Med 2000 Jan;124(1):61-70. [38 references]

    5. Practice parameter for the use of red blood cell transfusions. (NGC-0598)
      • Simon TL, Alverson DC, AuBuchon J, Cooper ES, DeChristopher PJ, Glenn GC, Gould SA, Harrison CR, Milam JD, Moise KJ Jr, Rodwig FR Jr, Sherman LA, Shulman IA, Stehling L. Practice parameter for the use of red blood cell transfusions: developed by the Red Blood Cell Administration Practice Guideline Development Task Force of the College of American Pathologists. Arch Pathol Lab Med 1998 Feb;122(2):130-8. [69 references] PubMed

    6. The preoperative bleeding time test lacks clinical benefit. (NGC-0599)
      • Peterson P, Hayes TE, Arkin CF, Bovill EG, Fairweather RB, Rock WA Jr, Triplett DA, Brandt JT. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998 Feb;133(2):134-9. [80 references] PubMed

    For more information, please refer to the College of American Pathologists Web site.

    Commission for the Establishment of Guidelines for Chiropractic Quality Assurance and Practice Parameters

    1. Guidelines for chiropractic quality assurance and practice parameters. (NGC-1048)
      • Guidelines for chiropractic quality assurance and practice parameters. Burlingame (CA): Aspen Publishers, Inc; 1993. 222 p. [1182 references]

    Community Collaboration on Healthcare Quality

    1. Long term management of asthma by classification in children < 5 years old. (NGC-1390)
      • Community Collaboration on Healthcare Quality (CCHQ). Long term management of asthma by classification in children less than or equal to 5 years old. Milwaukee, WI: Medical Society of Milwaukee County; 1998. 3 p. [0 references]